HomeExit StrategyHough Ear Institute Licenses Hearing Loss Treatment

Hough Ear Institute Licenses Hearing Loss Treatment

Hough Ear Institute licensed a novel hearing-loss treatment, which a local team of Hough scientists developed, to Boehringer Ingelheim, an international pharmaceutical firm.

The drug was codeveloped by OKC-based Autigen, a subsidiary of Otologic. Dr. Elaine Hamm is president of both.

“Our drug works to combat hearing loss caused by a loss of cells in the cochlea called ‘inner hair cells.’” Hamm said. “Previously, once you lost those, they wouldn’t grow back. Our drug causes them to grow back.”

Boehringer Ingelheim intends to take the drug through the testing process with the aim of bringing it to market. In preclinical models, the scientific team led by Drs. Xiaoping Du, Matthew West and Richard Kopke has regenerated these sensory hair cells.

Sign up for our weekly newsletter for our weekly newsletter and get the latest 405 news & events happening straight to your inbox!

Featured Stories

2022 Innovator Awards

New ideas, new products and new ways to approach problems are what alter, advance and propel companies forward. In fact, 50 percent of the...

“In Awe” of the Journey

Stephen and Staci Nelson spent more than a decade trying to have children. Now a decade removed from those struggles, they have six children...

Discovering Utopia

Sharina Perry wanted to reinvent petroleum-based plastics using sustainable, renewable materials. Two quick years and one pandemic later and Utopia Plastix is on the...